Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$156 Sell
3
-6
-67% -$313 ﹤0.01% 4118
2026
Q1
$417 Buy
9
+1
+13% +$53 ﹤0.01% 4020
2025
Q4
$421 Buy
8
+3
+60% +$152 ﹤0.01% 3930
2025
Q3
$272 Buy
+5
New +$268 ﹤0.01% 3915
2020
Q3
Sell
-38
Closed -$2K 3855
2020
Q2
$2K Sell
38
-118
-76% -$4.75K ﹤0.01% 3540
2020
Q1
$6K Buy
156
+21
+16% +$1.16K ﹤0.01% 3210
2019
Q4
$9K Buy
135
+17
+14% +$1.04K ﹤0.01% 3148
2019
Q3
$7K Buy
+118
New +$8.09K ﹤0.01% 3166
2014
Q3
Sell
-5
Closed -$1K 3578
2014
Q2
$1K Sell
5
-26
-84% -$5.47K ﹤0.01% 3439
2014
Q1
$7K Buy
31
+29
+1,450% +$7.45K ﹤0.01% 3131
2013
Q4
$1K Buy
+2
New +$639 ﹤0.01% 3363

Other funds holding VEON

US Bancorp's VEON Position: Q2 2026 in Review

US Bancorp reduced its VEON (VEON) stake by 67% in Q2 2026, selling an estimated $313 and leaving 3 shares worth $156. The position accounts for ﹤0.01% of the portfolio, ranked #4118.

US Bancorp first reported a position in VEON in Q4 2013 and has held it in 11 quarters since. The position peaked at $9K in Q4 2019. 111 funds tracked by Wall St. Rank hold VEON as of Q2 2026.

  • US Bancorp held 3 shares of VEON worth $156 as of Q2 2026.
  • US Bancorp sold 6 VEON shares in Q2 2026, an estimated $313.
  • VEON made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #4118 holding.
  • US Bancorp first reported a position in VEON in Q4 2013 and has held it in 11 quarters since.
  • US Bancorp's VEON position peaked at $9K in Q4 2019.
  • 111 funds tracked by Wall St. Rank held VEON as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.